Compass Wealth Management LLC

Position in ABBV — AbbVie Inc.

CIK 1965653 GUILFORD, CT

Position in ABBV

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$6,499,357

+$816,779 QoQ

Shares Held

25,828

-1.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.37%

of 13F equity value

Holder Rank

#1,152

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Compass Wealth Management LLC holds $18,364,693 across 8 Drug Manufacturers - General names. ABBV ranks #2 (35.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,093	$7,308,127
2	ABBV	AbbVie Inc. This page	25,828	$6,499,357
3	NVS	Novartis AG	12,747	$1,997,709
4	JNJ	Johnson & Johnson	3,985	$1,012,070
5	MRK	Merck & Co., Inc.	6,487	$833,579
6	BMY	Bristol Myers Squibb Co	5,648	$325,437
7	AMGN	Amgen Inc	775	$280,643
8	GRFS	Grifols SA	15,222	$107,771

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,499,357	25,828	-1.1%	Shares	Sole	2026-08-10
2026-03-31	$5,682,578	26,128	-5.3%	Shares	Sole	2026-04-21
2025-12-31	$6,306,324	27,600	-4.3%	Shares	Sole	2026-02-11
2025-09-30	$6,675,298	28,830	+0.2%	Shares	Sole	2025-11-07
2025-06-30	$5,342,143	28,780	-0.2%	Shares	Sole	2025-08-08
2025-03-31	$6,039,414	28,825	-2.5%	Shares	Sole	2025-04-29
2024-12-31	$5,254,944	29,572	+5.2%	Shares	Sole	2025-01-21
2024-09-30	$5,553,730	28,123	-4.1%	Shares	Sole	2024-10-16
2024-06-30	$5,031,367	29,334	+2.5%	Shares	Sole	2024-07-16
2024-03-31	$5,212,430	28,624	+2.1%	Shares	Sole	2024-04-05
2023-12-31	$4,345,978	28,044	+11.6%	Shares	Sole	2024-01-04
2023-09-30	$3,745,728	25,129	+5.7%	Shares	Sole	2023-10-25
2023-06-30	$3,201,993	23,766	-1.0%	Shares	Sole	2023-07-27
2023-03-31	$3,827,748	24,018	-2.6%	Shares	Sole	2023-05-15
2022-12-31	$3,984,171	24,653	—	Shares	Sole	2023-02-17
No filing history on record for this holder in this stock.